- Conditions
- HIV/AIDS
- Interventions
- Cabotegravir Injection
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 125 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Portland, Oregon
Source: ClinicalTrials.gov public record
Updated Dec 5, 2023 · Synced May 22, 2026, 4:10 AM EDT